Company news
Relay Therapeutics, Inc. (NASDAQ:RLAY) news
Relay Therapeutics, Inc. news releases on 6ix. Latest, Mar 25, 2021: Relay Therapeutics Reports Fourth Quarter and Full Year 2020 Financial Results…
Press releases — page 3
Relay Therapeutics Reports Fourth Quarter and Full Year 2020 Financial Results and Operational Highlights
March 24, 2021
Relay Therapeutics to Present Preclinical Data on RLY-4008 at AACR Annual Meeting
March 9, 2021
Relay Therapeutics to Participate in Fireside Chat at Guggenheim Healthcare Talks 2021 Oncology Day
February 3, 2021
Relay Therapeutics to Present at 39th Annual J.P. Morgan Healthcare Conference
January 5, 2021
Relay Therapeutics Announces a Worldwide License and Collaboration Agreement with Genentech for RLY-1971
December 13, 2020
Relay Therapeutics Reports Third Quarter 2020 Financial Results
November 11, 2020
Relay Therapeutics Announces Dosing of First Patient in First-in-Human Clinical Trial of RLY-4008, a Highly Selective FGFR2 Inhibitor
September 2, 2020
Relay Therapeutics Reports Second Quarter 2020 Financial Results
August 26, 2020
Relay Therapeutics Announces Closing of Initial Public Offering and Full Exercise of Underwriters’ Option to Purchase Additional Shares
July 19, 2020